Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2025-12-30 @ 8:21 PM
Study NCT ID:
NCT01441804
Status:
UNKNOWN
Last Update Posted:
2013-10-01
First Post:
2011-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism
Sponsor:
Third Affiliated Hospital, Sun Yat-Sen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TAHG1IL-28BCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None